Global Hereditary Disease Testing Supply, Demand and Key Producers, 2023-2029
The global Hereditary Disease Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Hereditary Disease Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hereditary Disease Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hereditary Disease Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hereditary Disease Testing total market, 2018-2029, (USD Million)
Global Hereditary Disease Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Hereditary Disease Testing total market, key domestic companies and share, (USD Million)
Global Hereditary Disease Testing revenue by player and market share 2018-2023, (USD Million)
Global Hereditary Disease Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Hereditary Disease Testing total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Hereditary Disease Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical and Agilent Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hereditary Disease Testing market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hereditary Disease Testing Market, By Region:
1. How big is the global Hereditary Disease Testing market?
2. What is the demand of the global Hereditary Disease Testing market?
3. What is the year over year growth of the global Hereditary Disease Testing market?
4. What is the total value of the global Hereditary Disease Testing market?
5. Who are the major players in the global Hereditary Disease Testing market?
This report studies the global Hereditary Disease Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hereditary Disease Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hereditary Disease Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hereditary Disease Testing total market, 2018-2029, (USD Million)
Global Hereditary Disease Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Hereditary Disease Testing total market, key domestic companies and share, (USD Million)
Global Hereditary Disease Testing revenue by player and market share 2018-2023, (USD Million)
Global Hereditary Disease Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Hereditary Disease Testing total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Hereditary Disease Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical and Agilent Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hereditary Disease Testing market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hereditary Disease Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Hereditary Cancer Testing
- Hereditary Non-cancer Testing
- Hospital
- Clinic
- Laboratory
- Others
- Myriad Genetics
- Invitae
- Illumina
- Natera
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche
- Quest Diagnostics
- CooperSurgical
- Agilent Technologies
- Thermo Fisher Scientific
- Twist Bioscience
- Sophia Genetics
- Fulgent Genetic
- Medgenome
- CENTOGENE
1. How big is the global Hereditary Disease Testing market?
2. What is the demand of the global Hereditary Disease Testing market?
3. What is the year over year growth of the global Hereditary Disease Testing market?
4. What is the total value of the global Hereditary Disease Testing market?
5. Who are the major players in the global Hereditary Disease Testing market?
1 SUPPLY SUMMARY
1.1 Hereditary Disease Testing Introduction
1.2 World Hereditary Disease Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Hereditary Disease Testing Total Market by Region (by Headquarter Location)
1.3.1 World Hereditary Disease Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Hereditary Disease Testing Market Size (2018-2029)
1.3.3 China Hereditary Disease Testing Market Size (2018-2029)
1.3.4 Europe Hereditary Disease Testing Market Size (2018-2029)
1.3.5 Japan Hereditary Disease Testing Market Size (2018-2029)
1.3.6 South Korea Hereditary Disease Testing Market Size (2018-2029)
1.3.7 ASEAN Hereditary Disease Testing Market Size (2018-2029)
1.3.8 India Hereditary Disease Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hereditary Disease Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hereditary Disease Testing Major Market Trends
2 DEMAND SUMMARY
2.1 World Hereditary Disease Testing Consumption Value (2018-2029)
2.2 World Hereditary Disease Testing Consumption Value by Region
2.2.1 World Hereditary Disease Testing Consumption Value by Region (2018-2023)
2.2.2 World Hereditary Disease Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Hereditary Disease Testing Consumption Value (2018-2029)
2.4 China Hereditary Disease Testing Consumption Value (2018-2029)
2.5 Europe Hereditary Disease Testing Consumption Value (2018-2029)
2.6 Japan Hereditary Disease Testing Consumption Value (2018-2029)
2.7 South Korea Hereditary Disease Testing Consumption Value (2018-2029)
2.8 ASEAN Hereditary Disease Testing Consumption Value (2018-2029)
2.9 India Hereditary Disease Testing Consumption Value (2018-2029)
3 WORLD HEREDITARY DISEASE TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Hereditary Disease Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Hereditary Disease Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Hereditary Disease Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Hereditary Disease Testing in 2022
3.3 Hereditary Disease Testing Company Evaluation Quadrant
3.4 Hereditary Disease Testing Market: Overall Company Footprint Analysis
3.4.1 Hereditary Disease Testing Market: Region Footprint
3.4.2 Hereditary Disease Testing Market: Company Product Type Footprint
3.4.3 Hereditary Disease Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Hereditary Disease Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Hereditary Disease Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Hereditary Disease Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Hereditary Disease Testing Consumption Value Comparison
4.2.1 United States VS China: Hereditary Disease Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hereditary Disease Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Hereditary Disease Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Hereditary Disease Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Hereditary Disease Testing Revenue, (2018-2023)
4.4 China Based Companies Hereditary Disease Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Hereditary Disease Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Hereditary Disease Testing Revenue, (2018-2023)
4.5 Rest of World Based Hereditary Disease Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Hereditary Disease Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Hereditary Disease Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Hereditary Disease Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hereditary Cancer Testing
5.2.2 Hereditary Non-cancer Testing
5.3 Market Segment by Type
5.3.1 World Hereditary Disease Testing Market Size by Type (2018-2023)
5.3.2 World Hereditary Disease Testing Market Size by Type (2024-2029)
5.3.3 World Hereditary Disease Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hereditary Disease Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Laboratory
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Hereditary Disease Testing Market Size by Application (2018-2023)
6.3.2 World Hereditary Disease Testing Market Size by Application (2024-2029)
6.3.3 World Hereditary Disease Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Myriad Genetics
7.1.1 Myriad Genetics Details
7.1.2 Myriad Genetics Major Business
7.1.3 Myriad Genetics Hereditary Disease Testing Product and Services
7.1.4 Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Myriad Genetics Recent Developments/Updates
7.1.6 Myriad Genetics Competitive Strengths & Weaknesses
7.2 Invitae
7.2.1 Invitae Details
7.2.2 Invitae Major Business
7.2.3 Invitae Hereditary Disease Testing Product and Services
7.2.4 Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Invitae Recent Developments/Updates
7.2.6 Invitae Competitive Strengths & Weaknesses
7.3 Illumina
7.3.1 Illumina Details
7.3.2 Illumina Major Business
7.3.3 Illumina Hereditary Disease Testing Product and Services
7.3.4 Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Illumina Recent Developments/Updates
7.3.6 Illumina Competitive Strengths & Weaknesses
7.4 Natera
7.4.1 Natera Details
7.4.2 Natera Major Business
7.4.3 Natera Hereditary Disease Testing Product and Services
7.4.4 Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Natera Recent Developments/Updates
7.4.6 Natera Competitive Strengths & Weaknesses
7.5 Laboratory Corporation of America Holdings
7.5.1 Laboratory Corporation of America Holdings Details
7.5.2 Laboratory Corporation of America Holdings Major Business
7.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Services
7.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Laboratory Corporation of America Holdings Recent Developments/Updates
7.5.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Details
7.6.2 F. Hoffmann-La Roche Major Business
7.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Product and Services
7.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 F. Hoffmann-La Roche Recent Developments/Updates
7.6.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
7.7 Quest Diagnostics
7.7.1 Quest Diagnostics Details
7.7.2 Quest Diagnostics Major Business
7.7.3 Quest Diagnostics Hereditary Disease Testing Product and Services
7.7.4 Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Quest Diagnostics Recent Developments/Updates
7.7.6 Quest Diagnostics Competitive Strengths & Weaknesses
7.8 CooperSurgical
7.8.1 CooperSurgical Details
7.8.2 CooperSurgical Major Business
7.8.3 CooperSurgical Hereditary Disease Testing Product and Services
7.8.4 CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 CooperSurgical Recent Developments/Updates
7.8.6 CooperSurgical Competitive Strengths & Weaknesses
7.9 Agilent Technologies
7.9.1 Agilent Technologies Details
7.9.2 Agilent Technologies Major Business
7.9.3 Agilent Technologies Hereditary Disease Testing Product and Services
7.9.4 Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Agilent Technologies Recent Developments/Updates
7.9.6 Agilent Technologies Competitive Strengths & Weaknesses
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Details
7.10.2 Thermo Fisher Scientific Major Business
7.10.3 Thermo Fisher Scientific Hereditary Disease Testing Product and Services
7.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Thermo Fisher Scientific Recent Developments/Updates
7.10.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.11 Twist Bioscience
7.11.1 Twist Bioscience Details
7.11.2 Twist Bioscience Major Business
7.11.3 Twist Bioscience Hereditary Disease Testing Product and Services
7.11.4 Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Twist Bioscience Recent Developments/Updates
7.11.6 Twist Bioscience Competitive Strengths & Weaknesses
7.12 Sophia Genetics
7.12.1 Sophia Genetics Details
7.12.2 Sophia Genetics Major Business
7.12.3 Sophia Genetics Hereditary Disease Testing Product and Services
7.12.4 Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Sophia Genetics Recent Developments/Updates
7.12.6 Sophia Genetics Competitive Strengths & Weaknesses
7.13 Fulgent Genetic
7.13.1 Fulgent Genetic Details
7.13.2 Fulgent Genetic Major Business
7.13.3 Fulgent Genetic Hereditary Disease Testing Product and Services
7.13.4 Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Fulgent Genetic Recent Developments/Updates
7.13.6 Fulgent Genetic Competitive Strengths & Weaknesses
7.14 Medgenome
7.14.1 Medgenome Details
7.14.2 Medgenome Major Business
7.14.3 Medgenome Hereditary Disease Testing Product and Services
7.14.4 Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Medgenome Recent Developments/Updates
7.14.6 Medgenome Competitive Strengths & Weaknesses
7.15 CENTOGENE
7.15.1 CENTOGENE Details
7.15.2 CENTOGENE Major Business
7.15.3 CENTOGENE Hereditary Disease Testing Product and Services
7.15.4 CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 CENTOGENE Recent Developments/Updates
7.15.6 CENTOGENE Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hereditary Disease Testing Industry Chain
8.2 Hereditary Disease Testing Upstream Analysis
8.3 Hereditary Disease Testing Midstream Analysis
8.4 Hereditary Disease Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Hereditary Disease Testing Introduction
1.2 World Hereditary Disease Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Hereditary Disease Testing Total Market by Region (by Headquarter Location)
1.3.1 World Hereditary Disease Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Hereditary Disease Testing Market Size (2018-2029)
1.3.3 China Hereditary Disease Testing Market Size (2018-2029)
1.3.4 Europe Hereditary Disease Testing Market Size (2018-2029)
1.3.5 Japan Hereditary Disease Testing Market Size (2018-2029)
1.3.6 South Korea Hereditary Disease Testing Market Size (2018-2029)
1.3.7 ASEAN Hereditary Disease Testing Market Size (2018-2029)
1.3.8 India Hereditary Disease Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hereditary Disease Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hereditary Disease Testing Major Market Trends
2 DEMAND SUMMARY
2.1 World Hereditary Disease Testing Consumption Value (2018-2029)
2.2 World Hereditary Disease Testing Consumption Value by Region
2.2.1 World Hereditary Disease Testing Consumption Value by Region (2018-2023)
2.2.2 World Hereditary Disease Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Hereditary Disease Testing Consumption Value (2018-2029)
2.4 China Hereditary Disease Testing Consumption Value (2018-2029)
2.5 Europe Hereditary Disease Testing Consumption Value (2018-2029)
2.6 Japan Hereditary Disease Testing Consumption Value (2018-2029)
2.7 South Korea Hereditary Disease Testing Consumption Value (2018-2029)
2.8 ASEAN Hereditary Disease Testing Consumption Value (2018-2029)
2.9 India Hereditary Disease Testing Consumption Value (2018-2029)
3 WORLD HEREDITARY DISEASE TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Hereditary Disease Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Hereditary Disease Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Hereditary Disease Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Hereditary Disease Testing in 2022
3.3 Hereditary Disease Testing Company Evaluation Quadrant
3.4 Hereditary Disease Testing Market: Overall Company Footprint Analysis
3.4.1 Hereditary Disease Testing Market: Region Footprint
3.4.2 Hereditary Disease Testing Market: Company Product Type Footprint
3.4.3 Hereditary Disease Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Hereditary Disease Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Hereditary Disease Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Hereditary Disease Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Hereditary Disease Testing Consumption Value Comparison
4.2.1 United States VS China: Hereditary Disease Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hereditary Disease Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Hereditary Disease Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Hereditary Disease Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Hereditary Disease Testing Revenue, (2018-2023)
4.4 China Based Companies Hereditary Disease Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Hereditary Disease Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Hereditary Disease Testing Revenue, (2018-2023)
4.5 Rest of World Based Hereditary Disease Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Hereditary Disease Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Hereditary Disease Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Hereditary Disease Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hereditary Cancer Testing
5.2.2 Hereditary Non-cancer Testing
5.3 Market Segment by Type
5.3.1 World Hereditary Disease Testing Market Size by Type (2018-2023)
5.3.2 World Hereditary Disease Testing Market Size by Type (2024-2029)
5.3.3 World Hereditary Disease Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hereditary Disease Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Laboratory
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Hereditary Disease Testing Market Size by Application (2018-2023)
6.3.2 World Hereditary Disease Testing Market Size by Application (2024-2029)
6.3.3 World Hereditary Disease Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Myriad Genetics
7.1.1 Myriad Genetics Details
7.1.2 Myriad Genetics Major Business
7.1.3 Myriad Genetics Hereditary Disease Testing Product and Services
7.1.4 Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Myriad Genetics Recent Developments/Updates
7.1.6 Myriad Genetics Competitive Strengths & Weaknesses
7.2 Invitae
7.2.1 Invitae Details
7.2.2 Invitae Major Business
7.2.3 Invitae Hereditary Disease Testing Product and Services
7.2.4 Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Invitae Recent Developments/Updates
7.2.6 Invitae Competitive Strengths & Weaknesses
7.3 Illumina
7.3.1 Illumina Details
7.3.2 Illumina Major Business
7.3.3 Illumina Hereditary Disease Testing Product and Services
7.3.4 Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Illumina Recent Developments/Updates
7.3.6 Illumina Competitive Strengths & Weaknesses
7.4 Natera
7.4.1 Natera Details
7.4.2 Natera Major Business
7.4.3 Natera Hereditary Disease Testing Product and Services
7.4.4 Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Natera Recent Developments/Updates
7.4.6 Natera Competitive Strengths & Weaknesses
7.5 Laboratory Corporation of America Holdings
7.5.1 Laboratory Corporation of America Holdings Details
7.5.2 Laboratory Corporation of America Holdings Major Business
7.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Services
7.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Laboratory Corporation of America Holdings Recent Developments/Updates
7.5.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Details
7.6.2 F. Hoffmann-La Roche Major Business
7.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Product and Services
7.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 F. Hoffmann-La Roche Recent Developments/Updates
7.6.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
7.7 Quest Diagnostics
7.7.1 Quest Diagnostics Details
7.7.2 Quest Diagnostics Major Business
7.7.3 Quest Diagnostics Hereditary Disease Testing Product and Services
7.7.4 Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Quest Diagnostics Recent Developments/Updates
7.7.6 Quest Diagnostics Competitive Strengths & Weaknesses
7.8 CooperSurgical
7.8.1 CooperSurgical Details
7.8.2 CooperSurgical Major Business
7.8.3 CooperSurgical Hereditary Disease Testing Product and Services
7.8.4 CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 CooperSurgical Recent Developments/Updates
7.8.6 CooperSurgical Competitive Strengths & Weaknesses
7.9 Agilent Technologies
7.9.1 Agilent Technologies Details
7.9.2 Agilent Technologies Major Business
7.9.3 Agilent Technologies Hereditary Disease Testing Product and Services
7.9.4 Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Agilent Technologies Recent Developments/Updates
7.9.6 Agilent Technologies Competitive Strengths & Weaknesses
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Details
7.10.2 Thermo Fisher Scientific Major Business
7.10.3 Thermo Fisher Scientific Hereditary Disease Testing Product and Services
7.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Thermo Fisher Scientific Recent Developments/Updates
7.10.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.11 Twist Bioscience
7.11.1 Twist Bioscience Details
7.11.2 Twist Bioscience Major Business
7.11.3 Twist Bioscience Hereditary Disease Testing Product and Services
7.11.4 Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Twist Bioscience Recent Developments/Updates
7.11.6 Twist Bioscience Competitive Strengths & Weaknesses
7.12 Sophia Genetics
7.12.1 Sophia Genetics Details
7.12.2 Sophia Genetics Major Business
7.12.3 Sophia Genetics Hereditary Disease Testing Product and Services
7.12.4 Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Sophia Genetics Recent Developments/Updates
7.12.6 Sophia Genetics Competitive Strengths & Weaknesses
7.13 Fulgent Genetic
7.13.1 Fulgent Genetic Details
7.13.2 Fulgent Genetic Major Business
7.13.3 Fulgent Genetic Hereditary Disease Testing Product and Services
7.13.4 Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Fulgent Genetic Recent Developments/Updates
7.13.6 Fulgent Genetic Competitive Strengths & Weaknesses
7.14 Medgenome
7.14.1 Medgenome Details
7.14.2 Medgenome Major Business
7.14.3 Medgenome Hereditary Disease Testing Product and Services
7.14.4 Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Medgenome Recent Developments/Updates
7.14.6 Medgenome Competitive Strengths & Weaknesses
7.15 CENTOGENE
7.15.1 CENTOGENE Details
7.15.2 CENTOGENE Major Business
7.15.3 CENTOGENE Hereditary Disease Testing Product and Services
7.15.4 CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 CENTOGENE Recent Developments/Updates
7.15.6 CENTOGENE Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hereditary Disease Testing Industry Chain
8.2 Hereditary Disease Testing Upstream Analysis
8.3 Hereditary Disease Testing Midstream Analysis
8.4 Hereditary Disease Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Hereditary Disease Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Hereditary Disease Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Hereditary Disease Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Hereditary Disease Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Hereditary Disease Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Hereditary Disease Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Hereditary Disease Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Hereditary Disease Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Hereditary Disease Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Hereditary Disease Testing Players in 2022
Table 12. World Hereditary Disease Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Hereditary Disease Testing Company Evaluation Quadrant
Table 14. Head Office of Key Hereditary Disease Testing Player
Table 15. Hereditary Disease Testing Market: Company Product Type Footprint
Table 16. Hereditary Disease Testing Market: Company Product Application Footprint
Table 17. Hereditary Disease Testing Mergers & Acquisitions Activity
Table 18. United States VS China Hereditary Disease Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Hereditary Disease Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Hereditary Disease Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Hereditary Disease Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Hereditary Disease Testing Revenue Market Share (2018-2023)
Table 23. China Based Hereditary Disease Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Hereditary Disease Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Hereditary Disease Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Hereditary Disease Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Hereditary Disease Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Hereditary Disease Testing Revenue Market Share (2018-2023)
Table 29. World Hereditary Disease Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Hereditary Disease Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Hereditary Disease Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Hereditary Disease Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Hereditary Disease Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Hereditary Disease Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Myriad Genetics Basic Information, Area Served and Competitors
Table 36. Myriad Genetics Major Business
Table 37. Myriad Genetics Hereditary Disease Testing Product and Services
Table 38. Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Myriad Genetics Recent Developments/Updates
Table 40. Myriad Genetics Competitive Strengths & Weaknesses
Table 41. Invitae Basic Information, Area Served and Competitors
Table 42. Invitae Major Business
Table 43. Invitae Hereditary Disease Testing Product and Services
Table 44. Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Invitae Recent Developments/Updates
Table 46. Invitae Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Area Served and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Hereditary Disease Testing Product and Services
Table 50. Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Natera Basic Information, Area Served and Competitors
Table 54. Natera Major Business
Table 55. Natera Hereditary Disease Testing Product and Services
Table 56. Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Natera Recent Developments/Updates
Table 58. Natera Competitive Strengths & Weaknesses
Table 59. Laboratory Corporation of America Holdings Basic Information, Area Served and Competitors
Table 60. Laboratory Corporation of America Holdings Major Business
Table 61. Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Services
Table 62. Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 64. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
Table 65. F. Hoffmann-La Roche Basic Information, Area Served and Competitors
Table 66. F. Hoffmann-La Roche Major Business
Table 67. F. Hoffmann-La Roche Hereditary Disease Testing Product and Services
Table 68. F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. F. Hoffmann-La Roche Recent Developments/Updates
Table 70. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 71. Quest Diagnostics Basic Information, Area Served and Competitors
Table 72. Quest Diagnostics Major Business
Table 73. Quest Diagnostics Hereditary Disease Testing Product and Services
Table 74. Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Quest Diagnostics Recent Developments/Updates
Table 76. Quest Diagnostics Competitive Strengths & Weaknesses
Table 77. CooperSurgical Basic Information, Area Served and Competitors
Table 78. CooperSurgical Major Business
Table 79. CooperSurgical Hereditary Disease Testing Product and Services
Table 80. CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. CooperSurgical Recent Developments/Updates
Table 82. CooperSurgical Competitive Strengths & Weaknesses
Table 83. Agilent Technologies Basic Information, Area Served and Competitors
Table 84. Agilent Technologies Major Business
Table 85. Agilent Technologies Hereditary Disease Testing Product and Services
Table 86. Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Agilent Technologies Recent Developments/Updates
Table 88. Agilent Technologies Competitive Strengths & Weaknesses
Table 89. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 90. Thermo Fisher Scientific Major Business
Table 91. Thermo Fisher Scientific Hereditary Disease Testing Product and Services
Table 92. Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Thermo Fisher Scientific Recent Developments/Updates
Table 94. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 95. Twist Bioscience Basic Information, Area Served and Competitors
Table 96. Twist Bioscience Major Business
Table 97. Twist Bioscience Hereditary Disease Testing Product and Services
Table 98. Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Twist Bioscience Recent Developments/Updates
Table 100. Twist Bioscience Competitive Strengths & Weaknesses
Table 101. Sophia Genetics Basic Information, Area Served and Competitors
Table 102. Sophia Genetics Major Business
Table 103. Sophia Genetics Hereditary Disease Testing Product and Services
Table 104. Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Sophia Genetics Recent Developments/Updates
Table 106. Sophia Genetics Competitive Strengths & Weaknesses
Table 107. Fulgent Genetic Basic Information, Area Served and Competitors
Table 108. Fulgent Genetic Major Business
Table 109. Fulgent Genetic Hereditary Disease Testing Product and Services
Table 110. Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Fulgent Genetic Recent Developments/Updates
Table 112. Fulgent Genetic Competitive Strengths & Weaknesses
Table 113. Medgenome Basic Information, Area Served and Competitors
Table 114. Medgenome Major Business
Table 115. Medgenome Hereditary Disease Testing Product and Services
Table 116. Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Medgenome Recent Developments/Updates
Table 118. CENTOGENE Basic Information, Area Served and Competitors
Table 119. CENTOGENE Major Business
Table 120. CENTOGENE Hereditary Disease Testing Product and Services
Table 121. CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Hereditary Disease Testing Upstream (Raw Materials)
Table 123. Hereditary Disease Testing Typical Customers
List of Figure
Figure 1. Hereditary Disease Testing Picture
Figure 2. World Hereditary Disease Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hereditary Disease Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Hereditary Disease Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Hereditary Disease Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 13. Hereditary Disease Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Hereditary Disease Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Hereditary Disease Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Hereditary Disease Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Hereditary Disease Testing Markets in 2022
Figure 27. United States VS China: Hereditary Disease Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hereditary Disease Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Hereditary Disease Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Hereditary Disease Testing Market Size Market Share by Type in 2022
Figure 31. Hereditary Cancer Testing
Figure 32. Hereditary Non-cancer Testing
Figure 33. World Hereditary Disease Testing Market Size Market Share by Type (2018-2029)
Figure 34. World Hereditary Disease Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Hereditary Disease Testing Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Laboratory
Figure 39. Others
Figure 40. Hereditary Disease Testing Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Hereditary Disease Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Hereditary Disease Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Hereditary Disease Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Hereditary Disease Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Hereditary Disease Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Hereditary Disease Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Hereditary Disease Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Hereditary Disease Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Hereditary Disease Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Hereditary Disease Testing Players in 2022
Table 12. World Hereditary Disease Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Hereditary Disease Testing Company Evaluation Quadrant
Table 14. Head Office of Key Hereditary Disease Testing Player
Table 15. Hereditary Disease Testing Market: Company Product Type Footprint
Table 16. Hereditary Disease Testing Market: Company Product Application Footprint
Table 17. Hereditary Disease Testing Mergers & Acquisitions Activity
Table 18. United States VS China Hereditary Disease Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Hereditary Disease Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Hereditary Disease Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Hereditary Disease Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Hereditary Disease Testing Revenue Market Share (2018-2023)
Table 23. China Based Hereditary Disease Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Hereditary Disease Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Hereditary Disease Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Hereditary Disease Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Hereditary Disease Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Hereditary Disease Testing Revenue Market Share (2018-2023)
Table 29. World Hereditary Disease Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Hereditary Disease Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Hereditary Disease Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Hereditary Disease Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Hereditary Disease Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Hereditary Disease Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Myriad Genetics Basic Information, Area Served and Competitors
Table 36. Myriad Genetics Major Business
Table 37. Myriad Genetics Hereditary Disease Testing Product and Services
Table 38. Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Myriad Genetics Recent Developments/Updates
Table 40. Myriad Genetics Competitive Strengths & Weaknesses
Table 41. Invitae Basic Information, Area Served and Competitors
Table 42. Invitae Major Business
Table 43. Invitae Hereditary Disease Testing Product and Services
Table 44. Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Invitae Recent Developments/Updates
Table 46. Invitae Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Area Served and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Hereditary Disease Testing Product and Services
Table 50. Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Natera Basic Information, Area Served and Competitors
Table 54. Natera Major Business
Table 55. Natera Hereditary Disease Testing Product and Services
Table 56. Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Natera Recent Developments/Updates
Table 58. Natera Competitive Strengths & Weaknesses
Table 59. Laboratory Corporation of America Holdings Basic Information, Area Served and Competitors
Table 60. Laboratory Corporation of America Holdings Major Business
Table 61. Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Services
Table 62. Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 64. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
Table 65. F. Hoffmann-La Roche Basic Information, Area Served and Competitors
Table 66. F. Hoffmann-La Roche Major Business
Table 67. F. Hoffmann-La Roche Hereditary Disease Testing Product and Services
Table 68. F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. F. Hoffmann-La Roche Recent Developments/Updates
Table 70. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 71. Quest Diagnostics Basic Information, Area Served and Competitors
Table 72. Quest Diagnostics Major Business
Table 73. Quest Diagnostics Hereditary Disease Testing Product and Services
Table 74. Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Quest Diagnostics Recent Developments/Updates
Table 76. Quest Diagnostics Competitive Strengths & Weaknesses
Table 77. CooperSurgical Basic Information, Area Served and Competitors
Table 78. CooperSurgical Major Business
Table 79. CooperSurgical Hereditary Disease Testing Product and Services
Table 80. CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. CooperSurgical Recent Developments/Updates
Table 82. CooperSurgical Competitive Strengths & Weaknesses
Table 83. Agilent Technologies Basic Information, Area Served and Competitors
Table 84. Agilent Technologies Major Business
Table 85. Agilent Technologies Hereditary Disease Testing Product and Services
Table 86. Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Agilent Technologies Recent Developments/Updates
Table 88. Agilent Technologies Competitive Strengths & Weaknesses
Table 89. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 90. Thermo Fisher Scientific Major Business
Table 91. Thermo Fisher Scientific Hereditary Disease Testing Product and Services
Table 92. Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Thermo Fisher Scientific Recent Developments/Updates
Table 94. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 95. Twist Bioscience Basic Information, Area Served and Competitors
Table 96. Twist Bioscience Major Business
Table 97. Twist Bioscience Hereditary Disease Testing Product and Services
Table 98. Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Twist Bioscience Recent Developments/Updates
Table 100. Twist Bioscience Competitive Strengths & Weaknesses
Table 101. Sophia Genetics Basic Information, Area Served and Competitors
Table 102. Sophia Genetics Major Business
Table 103. Sophia Genetics Hereditary Disease Testing Product and Services
Table 104. Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Sophia Genetics Recent Developments/Updates
Table 106. Sophia Genetics Competitive Strengths & Weaknesses
Table 107. Fulgent Genetic Basic Information, Area Served and Competitors
Table 108. Fulgent Genetic Major Business
Table 109. Fulgent Genetic Hereditary Disease Testing Product and Services
Table 110. Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Fulgent Genetic Recent Developments/Updates
Table 112. Fulgent Genetic Competitive Strengths & Weaknesses
Table 113. Medgenome Basic Information, Area Served and Competitors
Table 114. Medgenome Major Business
Table 115. Medgenome Hereditary Disease Testing Product and Services
Table 116. Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Medgenome Recent Developments/Updates
Table 118. CENTOGENE Basic Information, Area Served and Competitors
Table 119. CENTOGENE Major Business
Table 120. CENTOGENE Hereditary Disease Testing Product and Services
Table 121. CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Hereditary Disease Testing Upstream (Raw Materials)
Table 123. Hereditary Disease Testing Typical Customers
List of Figure
Figure 1. Hereditary Disease Testing Picture
Figure 2. World Hereditary Disease Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hereditary Disease Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Hereditary Disease Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Hereditary Disease Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Hereditary Disease Testing Revenue (2018-2029) & (USD Million)
Figure 13. Hereditary Disease Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Hereditary Disease Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Hereditary Disease Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Hereditary Disease Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Hereditary Disease Testing Markets in 2022
Figure 27. United States VS China: Hereditary Disease Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hereditary Disease Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Hereditary Disease Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Hereditary Disease Testing Market Size Market Share by Type in 2022
Figure 31. Hereditary Cancer Testing
Figure 32. Hereditary Non-cancer Testing
Figure 33. World Hereditary Disease Testing Market Size Market Share by Type (2018-2029)
Figure 34. World Hereditary Disease Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Hereditary Disease Testing Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Laboratory
Figure 39. Others
Figure 40. Hereditary Disease Testing Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
